# Aventus Thrombectomy System Pulmonary Embolism Clinical Study

Study · id `cardio:ct-nct05907564` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05907564](<https://clinicaltrials.gov/study/NCT05907564>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT05907564

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 120 participants.

## Technical summary

Registry record NCT05907564. Allocation not applicable; no masking; primary purpose treatment. Start 2023-09-20 (actual); primary completion 2025-02-20 (actual). Results posted on 2026-09-04.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 120 participants (enrolled count; ClinicalTrials.gov record NCT05907564, source copy `cardio:ctgov-nct05907564-2026-09-04`, retrieved 2026-10-31)
- Started: 2023-09-20 (actual) (ClinicalTrials.gov record NCT05907564, source copy `cardio:ctgov-nct05907564-2026-09-04`, retrieved 2026-10-31)
- Primary completion: 2025-02-20 (actual) (ClinicalTrials.gov record NCT05907564, source copy `cardio:ctgov-nct05907564-2026-09-04`, retrieved 2026-10-31)
- Completion: 2027-02 (anticipated) (ClinicalTrials.gov record NCT05907564, source copy `cardio:ctgov-nct05907564-2026-09-04`, retrieved 2026-10-31)
- Results first posted: 2026-09-04 (ClinicalTrials.gov record NCT05907564, source copy `cardio:ctgov-nct05907564-2026-09-04`, retrieved 2026-10-31)
- Countries: United States (ClinicalTrials.gov record NCT05907564, source copy `cardio:ctgov-nct05907564-2026-09-04`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05907564-2026-09-04`, retrieved 2026-10-31)

## The registry's words

- Brief title: Aventus Thrombectomy System Pulmonary Embolism Clinical Study
- Condition: Pulmonary Embolism
- Condition: Embolism
- Condition: Embolism and Thrombosis
- Condition: Vascular Diseases
- Condition: Cardiovascular Diseases
- Condition: Lung Diseases
- Condition: Respiratory Tract Diseases
- Intervention (Device): Thrombectomy
- Lead sponsor: Inquis Medical, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Pulmonary embolism (`cardio:pulmonary-embolism`)

## Provenance

Content hash: a018624b222eb001a3626a1a2a58bcfa31358a02645bcf74eb8728de71ae881d
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
